NCT07470489 2026-04-16Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid CancerM.D. Anderson Cancer CenterPhase 2 Not yet recruiting12 enrolled
NCT07179315 2026-03-04A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After TreatmentUniversity of ChicagoPhase 2 Not yet recruiting68 enrolled